US Map / South Carolina
State SC

Clinical Trials in South Carolina

Recruiting clinical trials with at least one study location in South Carolina. Data updated daily from ClinicalTrials.gov.

Total Trials
164
Recruiting Now
164
← Back to US Map
Top Conditions in South Carolina
Malignant Solid Neoplasm (4)Prostate Cancer (3)Atopic Dermatitis (3)Colorectal Cancer (3)Triple Negative Breast Cancer (3)Lung Non-Small Cell Carcinoma (2)Melanoma (2)Obesity (2)Weight Loss (2)Myasthenia Gravis (2)Hematopoietic and Lymphatic System Neoplasm (2)Acute Myeloid Leukemia (2)
NCT06039566 Phase 3
Recruiting
NAC vs Placebo on Opioid Use for Hysterectomy
Condition
Hysterectomy
Enrollment
240 pts
Location
United States
Sponsor
Medical University of South Ca
View Trial →
NCT06774131 Phase 3
Recruiting
A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract...
Condition
Upper Urinary Tract Urothelial Carcinoma
Enrollment
70 pts
Location
United States, Bulgaria, Georgia
Sponsor
UroGen Pharma Ltd.
View Trial →
NCT06239350 N/A
Recruiting
Young Adult Tobacco/Nicotine and Cannabis Co-use
Condition
Tobacco Use Disorder
Enrollment
350 pts
Location
United States
Sponsor
Medical University of South Ca
View Trial →
NCT06072482 Phase 4
Recruiting
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
Condition
Antineutrophil Cytoplasmic Antibody-associated Vasculitis
Enrollment
300 pts
Location
United States, Czechia, Hungary
Sponsor
Amgen
View Trial →
NCT06752668 Phase 2
Recruiting
A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
Condition
Narcolepsy Type 1
Enrollment
96 pts
Location
United States, Canada
Sponsor
Centessa Pharmaceuticals (UK)
View Trial →
NCT06356571 Phase 2
Recruiting
A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfil...
Condition
Plasma Cell Myeloma Refractory
Enrollment
64 pts
Location
United States
Sponsor
Sanofi
View Trial →
NCT06410209 Phase 2
Recruiting
A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervent...
Condition
Hematopoietic and Lymphatic System Neoplasm
Enrollment
190 pts
Location
United States, Puerto Rico
Sponsor
Children's Oncology Group
View Trial →
NCT07037433 Phase 3
Recruiting
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in P...
Condition
Atherosclerotic Cardiovascular Disease
Enrollment
12,800 pts
Location
United States, Argentina, Australia
Sponsor
Amgen
View Trial →
NCT06799429 N/A
Recruiting
Train Your Brain SC: Exercise for People With Mild-moderate Cognitive Impairment...
Condition
Cognitive Impairment
Enrollment
50 pts
Location
United States
Sponsor
University of South Carolina
View Trial →
NCT04097145 N/A
Recruiting
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
Condition
Tricuspid Regurgitation
Enrollment
870 pts
Location
United States, Canada
Sponsor
Edwards Lifesciences
View Trial →
NCT06991556 Phase 2
Recruiting
An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone ...
Condition
Metastatic Hormone-sensitive Prostate Cancer
Enrollment
150 pts
Location
United States, Australia, Canada
Sponsor
Novartis Pharmaceuticals
View Trial →
NCT04951622 Phase 3
Recruiting
A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
Condition
Myasthenia Gravis
Enrollment
199 pts
Location
United States, Australia, Belgium
Sponsor
Janssen Research & Development
View Trial →
NCT07037901 Phase 2
Recruiting
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants Wit...
Condition
Atopic Dermatitis
Enrollment
220 pts
Location
United States, Canada
Sponsor
Inmagene LLC
View Trial →
NCT07225946 Phase 3
Recruiting
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metas...
Condition
Prostatic Neoplasms, Castration-Resistant
Enrollment
800 pts
Location
United States, Australia, Brazil
Sponsor
Janssen Research & Development
View Trial →
NCT06389877 Phase 1, Phase 2
Recruiting
A Study to Evaluate the Safety and Efficacy of BEAM-302 in Adult Patients With A...
Condition
Alpha 1-Antitrypsin Deficiency
Enrollment
106 pts
Location
United States, Australia, Ireland
Sponsor
Beam Therapeutics Inc.
View Trial →
NCT04557891 N/A
Recruiting
Low-Intensity Focused Ultrasound Pulsation (LIFUP) for the Treatment of Generali...
Condition
Generalized Anxiety Disorder
Enrollment
48 pts
Location
United States
Sponsor
University of California, Los
View Trial →
NCT05327686 Phase 2
Recruiting
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for t...
Condition
Metastatic Renal Cell Carcinoma
Enrollment
240 pts
Location
United States, Australia, Canada
Sponsor
NRG Oncology
View Trial →
NCT05337241 N/A
Recruiting
Saline Enhanced Radiofrequency (SERF) Needle Ablation for Refractory VT
Condition
Refractory Ventricular Tachycardia
Enrollment
130 pts
Location
United States, Canada
Sponsor
Thermedical, Inc.
View Trial →
NCT06384261 Phase 2
Recruiting
A Study Comparing Venetoclax and Azacitidine Plus Cusatuzumab to Venetoclax and ...
Condition
Leukemia, Myeloid, Acute
Enrollment
120 pts
Location
United States, Canada, Germany
Sponsor
OncoVerity, Inc.
View Trial →
NCT06973161 N/A
Recruiting
ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Sol...
Condition
Bladder Cancer
Enrollment
105 pts
Location
United States, Austria, Belgium
Sponsor
AstraZeneca
View Trial →
NCT03118986 Phase 2
Recruiting
RCT of Olanzapine for Control of CIV in Children Receiving Highly Emetogenic Che...
Condition
Vomiting in Infants and/or Children
Enrollment
200 pts
Location
United States, Canada, India
Sponsor
The Hospital for Sick Children
View Trial →
NCT04300556 Phase 1, Phase 2
Recruiting
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein ...
Condition
Solid Tumor
Enrollment
182 pts
Location
United States, France, Japan
Sponsor
Eisai Inc.
View Trial →
NCT07104383 Phase 3
Recruiting
VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)
Condition
Weight Loss
Enrollment
1,100 pts
Location
United States, Puerto Rico
Sponsor
Viking Therapeutics, Inc.
View Trial →
NCT06741527 N/A
Recruiting
Integrity Implant System Post Market Clinical Follow-Up Study
Condition
Rotator Cuff Tears of the Shoulder
Enrollment
150 pts
Location
United States
Sponsor
Anika Therapeutics, Inc.
View Trial →
NCT06136650 Phase 3
Recruiting
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Age...
Condition
Metastatic Castration-resistant Prostate Cancer (mCRPC)
Enrollment
1,314 pts
Location
United States, Australia, Brazil
Sponsor
Merck Sharp & Dohme LLC
View Trial →
Page 2 of 7 — 164 trials total
← Prev Next →